HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Federico Da Settimo Selected Research

9-(2-hydroxy-3-nonyl)adenine (EHNA)

11/2010The blockade of adenosine deaminase ameliorates chronic experimental colitis through the recruitment of adenosine A2A and A3 receptors.
8/2007Inhibition of adenosine deaminase attenuates inflammation in experimental colitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Federico Da Settimo Research Topics

Disease

18Neoplasms (Cancer)
04/2022 - 02/2009
9Glioma (Gliomas)
01/2018 - 03/2004
7Thyroid Neoplasms (Thyroid Cancer)
04/2018 - 02/2011
7Glioblastoma (Glioblastoma Multiforme)
01/2018 - 05/2010
6Diabetes Complications
11/2018 - 09/2009
5Neuroinflammatory Diseases
01/2022 - 01/2011
4Inflammation (Inflammations)
06/2016 - 08/2007
4Cataract (Cataracts)
06/2008 - 04/2003
3Anaplastic Thyroid Carcinoma
07/2016 - 04/2012
3Colitis
11/2010 - 08/2007
2Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 01/2014
2Poisoning
03/2019 - 09/2009
2Cardiovascular Diseases (Cardiovascular Disease)
01/2017 - 10/2016
2medullary Thyroid cancer
11/2014 - 02/2014
2Neuroblastoma
05/2014 - 09/2011
2Body Weight (Weight, Body)
11/2010 - 08/2007
1Obesity
04/2022
1Glaucoma
04/2022
1Epilepsy (Aura)
04/2022
1Renal Cell Carcinoma (Grawitz Tumor)
12/2021
1Osteoporosis
12/2021
1Alzheimer Disease (Alzheimer's Disease)
12/2021
1Colorectal Neoplasms (Colorectal Cancer)
04/2020
1Nervous System Diseases (Neurological Disorders)
01/2019
1Insulin Resistance
10/2016
1Heart Failure
10/2016
1Ischemia
10/2016
1Anxiety Disorders (Anxiety Disorder)
01/2016
1Multiple Endocrine Neoplasia Type 2b (MEN 3)
11/2014
1Osteoarthritis
04/2013
1Hyperglycemia
12/2012
1Sepsis (Septicemia)
06/2012
1Lung Diseases (Lung Disease)
06/2012
1Wounds and Injuries (Trauma)
06/2012
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
06/2012
1Rheumatoid Arthritis
06/2012
1Colonic Neoplasms (Colon Cancer)
05/2012
1Asthma (Bronchial Asthma)
05/2012
1Neoplasm Metastasis (Metastasis)
05/2012
1Diabetic Neuropathies (Diabetic Neuropathy)
05/2012

Drug/Important Bio-Agent (IBA)

16Proteins (Proteins, Gene)FDA Link
01/2022 - 06/2011
10LigandsIBA
01/2022 - 03/2004
9EnzymesIBA
12/2019 - 09/2009
8pyrimidineIBA
07/2016 - 08/2007
7Aldehyde Reductase (Aldose Reductase)IBA
11/2018 - 06/2008
4Biological ProductsIBA
04/2020 - 05/2010
4Phosphotransferases (Kinase)IBA
04/2019 - 02/2014
4ErbB Receptors (EGF Receptor)IBA
07/2016 - 02/2009
4Tyrosine Kinase InhibitorsIBA
11/2014 - 02/2011
4Adenosine (Adenocard)FDA LinkGeneric
06/2012 - 08/2007
4SolutionsIBA
06/2008 - 04/2003
4Ophthalmic Solutions (Eye Drops)IBA
06/2008 - 04/2003
3Purinergic P1 Receptors (Adenosine Receptor)IBA
12/2021 - 11/2010
3Biomarkers (Surrogate Marker)IBA
11/2021 - 01/2011
3Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
07/2016 - 04/2014
3NeurosteroidsIBA
06/2016 - 05/2011
3SteroidsIBA
01/2016 - 03/2004
3Pharmaceutical PreparationsIBA
03/2015 - 06/2011
3Adenosine DeaminaseIBA
06/2012 - 08/2007
32,4-dinitrobenzenesulfonic acidIBA
11/2010 - 08/2007
2Carbonic Anhydrases (Carbonic Anhydrase)IBA
12/2021 - 01/2016
2Protein Isoforms (Isoforms)IBA
12/2019 - 01/2016
2Protein Kinases (Protein Kinase)IBA
04/2019 - 02/2016
2Type I DNA Topoisomerases (Topoisomerase I)IBA
03/2019 - 09/2009
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
07/2016 - 04/2014
2Antineoplastic Agents (Antineoplastics)IBA
11/2014 - 02/2009
24- chloro- N- (1,1,3- trioxo- 2,3- dihydrobenzo(d)isothiazol- 4- yl)benzamideIBA
11/2014 - 04/2012
2AmidesIBA
11/2014 - 04/2012
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2014 - 04/2012
2GABA-A Receptors (GABA(A) Receptor)IBA
01/2014 - 06/2005
29-(2-hydroxy-3-nonyl)adenine (EHNA)IBA
11/2010 - 08/2007
2pyrazoleIBA
11/2010 - 08/2007
2Dexamethasone (Maxidex)FDA LinkGeneric
11/2010 - 08/2007
2EstersIBA
11/2005 - 04/2003
2ProdrugsIBA
11/2005 - 04/2003
2tolrestatIBA
01/2005 - 04/2003
1DiureticsIBA
04/2022
1CCG 1423IBA
12/2021
1BAY 60-6583IBA
12/2021
1IsoenzymesIBA
12/2018
1compound 106IBA
01/2018
1IntegrinsIBA
01/2018
1Hydrogen Sulfide (Sulfide, Hydrogen)IBA
01/2017
1GasotransmittersIBA
01/2017
1Insulin (Novolin)FDA Link
10/2016
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
02/2016
1CholesterolIBA
01/2016
1Temozolomide (Temodar)FDA LinkGeneric
01/2016
1Amyloid (Amyloid Fibrils)IBA
05/2014
14-phenylquinazoline-2-carboxamidesIBA
03/2014
1tyrosine receptor (receptor, tyrosine)IBA
02/2014
1ADAMTS5 ProteinIBA
04/2013
1Aggrecans (Aggrecan)IBA
04/2013
1aggrecanaseIBA
04/2013
1Peptide Hydrolases (Proteases)FDA Link
04/2013
1polyolIBA
12/2012
1fidarestatIBA
05/2012
11-Methyl-4-phenylpyridinium (1 Methyl 4 phenylpyridinium)IBA
09/2011

Therapy/Procedure

4Therapeutics
04/2022 - 04/2014
2Heterologous Transplantation (Xenotransplantation)
08/2014 - 02/2011